EDAP TMS (EDAP) Competitors $2.52 -0.23 (-8.36%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$2.48 -0.04 (-1.59%) As of 09/4/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EDAP vs. NPCE, SMTI, CLPT, TCMD, BWAY, DRTS, SKIN, TLSI, CATX, and OMShould you be buying EDAP TMS stock or one of its competitors? The main competitors of EDAP TMS include NeuroPace (NPCE), Sanara MedTech (SMTI), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Brainsway (BWAY), Alpha Tau Medical (DRTS), Beauty Health (SKIN), TriSalus Life Sciences (TLSI), Perspective Therapeutics (CATX), and Outset Medical (OM). These companies are all part of the "medical equipment" industry. EDAP TMS vs. Its Competitors NeuroPace Sanara MedTech ClearPoint Neuro Tactile Systems Technology Brainsway Alpha Tau Medical Beauty Health TriSalus Life Sciences Perspective Therapeutics Outset Medical EDAP TMS (NASDAQ:EDAP) and NeuroPace (NASDAQ:NPCE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability. Do analysts recommend EDAP or NPCE? EDAP TMS currently has a consensus target price of $8.50, suggesting a potential upside of 237.30%. NeuroPace has a consensus target price of $16.60, suggesting a potential upside of 72.74%. Given EDAP TMS's higher probable upside, equities analysts plainly believe EDAP TMS is more favorable than NeuroPace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EDAP TMS 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33NeuroPace 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Do institutionals & insiders have more ownership in EDAP or NPCE? 62.7% of EDAP TMS shares are owned by institutional investors. Comparatively, 78.8% of NeuroPace shares are owned by institutional investors. 0.2% of EDAP TMS shares are owned by company insiders. Comparatively, 20.5% of NeuroPace shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, EDAP or NPCE? EDAP TMS has a beta of -0.21, suggesting that its share price is 121% less volatile than the S&P 500. Comparatively, NeuroPace has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500. Does the media favor EDAP or NPCE? In the previous week, EDAP TMS and EDAP TMS both had 7 articles in the media. NeuroPace's average media sentiment score of 1.48 beat EDAP TMS's score of 0.50 indicating that NeuroPace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EDAP TMS 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive NeuroPace 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is EDAP or NPCE more profitable? NeuroPace has a net margin of -29.29% compared to EDAP TMS's net margin of -33.49%. EDAP TMS's return on equity of -56.85% beat NeuroPace's return on equity.Company Net Margins Return on Equity Return on Assets EDAP TMS-33.49% -56.85% -26.83% NeuroPace -29.29%-168.61%-25.48% Which has higher valuation and earnings, EDAP or NPCE? EDAP TMS has higher earnings, but lower revenue than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than EDAP TMS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEDAP TMS$69.18M1.36-$20.58M-$0.61-4.13NeuroPace$79.91M3.98-$27.14M-$0.84-11.44 SummaryNeuroPace beats EDAP TMS on 10 of the 15 factors compared between the two stocks. Get EDAP TMS News Delivered to You Automatically Sign up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EDAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EDAP vs. The Competition Export to ExcelMetricEDAP TMSMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$102.83M$6.90B$5.75B$9.85BDividend YieldN/A1.22%6.67%4.51%P/E Ratio-4.1326.0675.9926.43Price / Sales1.3670.07546.95119.09Price / CashN/A21.6037.0558.92Price / Book2.144.9010.916.06Net Income-$20.58M$178.27M$3.29B$266.28M7 Day Performance11.50%-0.86%0.18%-0.32%1 Month Performance98.43%2.52%6.26%3.44%1 Year Performance-19.75%10.03%51.55%23.11% EDAP TMS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EDAPEDAP TMS2.554 of 5 stars$2.52-8.4%$8.50+237.3%-21.4%$102.83M$69.18M-4.13230Short Interest ↑NPCENeuroPace3.8581 of 5 stars$9.15+0.4%$16.60+81.4%+35.4%$302.70M$79.91M-10.89170Positive NewsSMTISanara MedTech2.0855 of 5 stars$33.66-0.2%$50.00+48.5%-1.6%$299.65M$86.67M-29.0260CLPTClearPoint Neuro1.8686 of 5 stars$10.49flat$19.67+87.5%-11.1%$298.20M$31.39M-12.95110TCMDTactile Systems Technology2.3609 of 5 stars$13.31+1.1%$13.50+1.4%+1.0%$296.71M$292.98M21.471,037Positive NewsBWAYBrainsway3.801 of 5 stars$15.56+1.4%$18.00+15.7%+110.7%$294.11M$41.02M59.85120Positive NewsShort Interest ↓DRTSAlpha Tau Medical2.012 of 5 stars$3.42+1.8%$9.00+163.2%+53.1%$290.08MN/A-7.1380Analyst ForecastSKINBeauty Health1.7128 of 5 stars$2.08+2.0%$2.63+26.2%+2.6%$263.80M$334.30M-7.431,030Trending NewsTLSITriSalus Life Sciences2.6706 of 5 stars$5.22+2.2%$10.75+105.9%+2.8%$260.31M$29.43M-4.42106Positive NewsCATXPerspective Therapeutics2.1019 of 5 stars$3.36-0.6%$12.56+273.7%-76.4%$249.52MN/A0.0070Positive NewsOMOutset Medical1.6585 of 5 stars$13.91-0.1%$24.67+77.3%+73.7%$247.13M$113.69M-0.69520 Related Companies and Tools Related Companies NeuroPace Competitors Sanara MedTech Competitors ClearPoint Neuro Competitors Tactile Systems Technology Competitors Brainsway Competitors Alpha Tau Medical Competitors Beauty Health Competitors TriSalus Life Sciences Competitors Perspective Therapeutics Competitors Outset Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EDAP) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EDAP TMS S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share EDAP TMS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EDAP Stock Alerts